Search Results
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
received at least one prior line of therapy. LYMPHIR was administered intravenously on Days 1–3 of each 21‑day cycle at escalating doses (3, 6, 9, and 12 mcg/kg), along with pembrolizumab (200 mg IV) on Day 1. Patients who completed eight cycles of combination therapy were continued on pembrolizumab monotherapy
More news about: Citius Oncology, Inc.
May 21, 2026, 09:00 ET Homecare Homebase Named "Best Overall Home Healthcare Solution Provider" in 10th Annual MedTech Breakthrough Awards Program
MCG,
More news about: Homecare Homebase
May 18, 2026, 14:05 ET Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Revefenacin Inhalation Solution, 175 mcg/3 mL Unit-Dose Vials.
More news about: Lupin Pharmaceuticals, Inc.
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
acid to include the full suite of helper nutrients folate metabolism requires. The formula provides a B-12 tri-blend (800 mcg methylcobalamin, 100 mcg adenosylcobalamin, 100 mcg hydroxocobalamin) for complete cellular coverage, active B-6 as pyridoxal-5′-phosphate (P-5-P, 5 mg) to support an additional
More news about: Triquetra Health LLC
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™ Adult Liquid--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
like."FolinicActive Adult Liquid delivers 1 mg folinic acid (as calcium folinate) per 0.50 mL serving alongside the Complete Tri-Cofactor System: 1,000 mcg Vitamin B-12 as a tri-blend (80% methylcobalamin, 10% adenosylcobalamin, 10% hydroxocobalamin), 5 mg active B-6 as pyridoxal-5′-phosphate (P-5-P), and
More news about: Triquetra Health LLC
May 15, 2026, 10:00 ET AMIA Amplify Poster Session: FDB Pharmacists Show Patient-Specific Medication Guidance Can Reduce Pharmacy Alerts by 70%
with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies, FDB, Homecare Homebase, MCG, MHK, QGenda, and Zynx Health, elevate care by informing and empowering participants across the health journey. Learn more at
More news about: FDB (First Databank)
May 14, 2026, 08:00 ET Natrol® Launches Ultra Sleep and Ultra Energy; Partners with Calm and Michelle Monaghan to Support the Full Sleep Cycle and 24-Hour Wellness
rested.†Natrol® Ultra Energy complements Ultra Sleep by delivering sustained cellular energy support:Vitamin B12: 1000mcg supports energy metabolism†B-Complex: Helps convert food into fuel and energizes cells from within†Vitamin D:
More news about: Natrol
May 13, 2026, 07:05 ET Media Consulting Group Appoints Gali Davidi as Chief AI Officer to Drive Agentic Innovation in Programmatic Media
workflows."Gali joins MCG with a reputation for shipping agentic systems that hold up under load. His expertise lies in the "second wave" of AI—moving beyond simple generative chat to agentic systems that use memory, tool-integration, and multi-step reasoning to solve enterprise-level challenges. At MCG, he will apply
More news about: Media Consulting Group
May 12, 2026, 08:00 ET Homecare Homebase Releases New Report on Responsible AI in Home-Based Care
MCG, MHK,
More news about: Homecare Homebase
May 11, 2026, 09:13 ET Transpire Bio's ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
furoate, umeclidinium, and vilanterol inhalation powder, a generic version of the high-strength Trelegy® Ellipta®1 (200 mcg/62.5 mcg/25 mcg) product, has been accepted for filing by the U.S. Food and Drug Administration (FDA).
More news about: Transpire Bio
May 07, 2026, 06:59 ET Viatris Reports First-Quarter 2026 Financial Results
Company announced that six abstracts on its investigational low dose estrogen weekly patch (150 mcg norelgestromin and 17.5 mcg ethinyl estradiol) for contraception were presented at the 2026 American College of Obstetricians and Gynecologists Annual Clinical &
More news about: Viatris Inc.
May 06, 2026, 10:23 ET FullWell Launches Strawberry-Flavor Capsule-Free Prenatal Stick Packs
packs.*Full ingredient list: Vitamin A (1500 mcg RAE), vitamin C (275 mg), vitamin D (100 mcg (4000 IU)), vitamin E (100 mg), thiamin (5 mg), riboflavin (10 mg), niacin (25 mg NE), vitamin B6 (10 mg), folate (1360 mcf DFE), vitamin B12 (150 mcg), biotin (500 mcg), pantothenic acid (150 mg), choline (300 mg),
More news about: FullWell
May 01, 2026, 06:59 ET Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
and represents a lifecycle advancement of the contraceptive patch, Xulane® (norelgestromin and ethinyl estradiol transdermal system) 150/35 mcg per day.About Viatris
More news about: Viatris Inc.
Apr 30, 2026, 10:00 ET FDB Launches Gravimetric Content to Strengthen Safety and Accuracy in IV Medication Compounding
with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies, FDB, Homecare Homebase, MCG, MHK, QGenda and Zynx Health, elevate care by informing and empowering participants across the health journey. To learn more, visit
More news about: FDB (First Databank)
Apr 29, 2026, 10:00 ET FDB Expert to Highlight AI's Emerging Impact on ePrescribing Workflows During NCPDP Annual Conference
care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies — FDB, Homecare Homebase, MCG, MHK, QGenda, and Zynx Health — elevate care by informing and empowering participants across the health journey. Learn more at
More news about: FDB (First Databank)
Apr 28, 2026, 07:00 ET Triquetra Health Launches BioActive B-Complex™ Liquid--First Formula with Five Active B-Vitamin Form Upgrades and Tri-Form B12 in Liquid Delivery
only B5 form with a dedicated cardiovascular RCT), Pyridoxal-5'-Phosphate for B6 (active coenzyme requiring no hepatic conversion), L-5-MTHF at 3,400 mcg DFE for B9 (7× Greater Plasma Folate Rise vs. Standard Folic Acid confirmed in peer-reviewed pharmacokinetic research), and a tri-form B12 complex covering
More news about: Triquetra Health LLC
Apr 23, 2026, 09:04 ET Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
'Cipla'), today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation from the United States Food and Drug Administration (USFDA). It is the first AB–rated generic therapeutic equivalent of Ventolin® HFA,
More news about: Cipla USA Inc.
Apr 21, 2026, 07:02 ET Media Consulting Group Appoints Industry Veteran Diana Horowitz as Strategic Advisor to Accelerate Go-To-Market Expansion
& CRO of MCG. "As we transition MCG into its next phase of growth—focusing on our proprietary platform's expansion—Diana's expertise in converged media and strategic sales will be invaluable. We are thrilled to have her guidance as we continue to innovate and scale."Horowitz joins MCG following
More news about: Media Consulting Group
Apr 15, 2026, 07:00 ET Concentrated Shatavari Nutraceutical Gummy Leads TopGum's New Women's Collection
racemocas) gummy with vitamin D. Each naturally flavored cherry chew packs in 150mg clinically endorsed SRI-80 shatavari root extract combined with 5mcg vitamin D. Labelled the "Queen of Herbs" in Ayurveda, shatavari is a purported adaptogen prized traditionally for its ability to support women through
More news about: TopGum Industries, Inc.
Apr 13, 2026, 07:35 ET Media Consulting Group Joins Index Marketplaces to Enable Structured Supply Activation and Upstream Performance Decisioning
buy-side performance lens upstream, MCG helps agencies enter campaigns with intentional, structured supply frameworks, addressing inefficiencies at the source rather than relying solely on downstream DSP-level adjustments.For agencies that choose to layer it in, MCG provides measurement and attribution
More news about: Media Consulting Group
Apr 09, 2026, 10:00 ET RxWallet® Goes Live on FDB Vela™, Expanding Real-Time Prescription Price Transparency for Consumers
MCG,
More news about: FDB (First Databank)
Apr 07, 2026, 09:31 ET MCG and Loma Linda University Health to Highlight AI-Driven Advances in Utilization and Case Management at ACMA 2026
https://events.acmaweb.org/website/84948/home/.About MCG HealthMCG, part of the Hearst Health network, is the trusted source of truth for clinical guidance in the healthcare industry. MCG combines evidence-based guidelines and analytics with artificial intelligence to guide efficient and accurate clinical decisions. MCG solutions are
More news about: MCG Health
Apr 01, 2026, 09:35 ET Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative Portfolio
manage end-to-end commercialization and distribution for RYALTRIS® (Olopatadine Hydrochloride and Mometasone Furoate) Nasal Spray, 665 mcg/25 mcg* per spray in the United States, effective April 1, 2026.
More news about: Glenmark Pharmaceuticals
Mar 31, 2026, 10:00 ET FDB Launches MedProof MCP™, Pioneering AI-Native Agentic Medication Workflows
care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies -- FDB, Homecare Homebase, MCG, MHK, QGenda, and Zynx Health -- elevate care by informing and empowering participants across the health journey. Learn more at
More news about: FDB (First Databank)
Mar 31, 2026, 09:45 ET St. Luke's University Health Network Honored with Richard L. Doyle Award for Innovative Care Planning
resources.About MCG HealthMCG, part of the Hearst Health network, is the trusted source of truth for clinical guidance in the healthcare industry. MCG combines evidence-based guidelines and analytics with artificial intelligence to guide efficient and accurate clinical decisions. MCG solutions are
More news about: MCG Health